Virtual Reality on Pain and Fear Level During Kirschner Wires (K-Wires) Removal in Children
Launched by ONDOKUZ MAYIS UNIVERSITY · Jan 30, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how virtual reality (VR) can help reduce pain and fear in children aged 7 to 12 who need to have Kirschner wires (K-wires) removed. K-wires are thin metal wires used in some orthopedic surgeries, and the removal process can be uncomfortable for kids. By using VR during the procedure, the study aims to see if it can make the experience less painful and scary for these young patients.
To participate in this study, children must be between 7 and 12 years old and scheduled for K-wire removal. They should not wear glasses and must be able to interact with a video selection. However, children who have chronic pain conditions, have taken pain-relieving medication in the last 24 hours, wear glasses, or have certain mental or neurological disabilities will not be eligible. If chosen to participate, kids will experience a VR environment while their K-wires are removed, which may help distract them and ease their discomfort. This study is not yet recruiting participants, but it aims to provide insights into making medical procedures less frightening for children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being a child between the ages of 7-12 who will have the K wire removed
- • The child is not using glasses
- • The child must be at a cognitive development level that can respond to video selection.
- Exclusion Criteria:
- • Having a disease that causes chronic pain
- • The child must have used medication that would have an analgesic effect in the last 24 hours before the application.
- • The child is wearing glasses
- • The child has a mental or neurological disability
About Ondokuz Mayıs University
Ondokuz Mayıs University is a prestigious academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its cutting-edge facilities and a multidisciplinary team of experts to conduct innovative studies that aim to enhance patient care and contribute to scientific knowledge. With a focus on ethical standards and rigorous methodologies, Ondokuz Mayıs University is dedicated to fostering collaborations that drive breakthroughs in healthcare, ultimately improving treatment outcomes and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, , Turkey
Samsun, Atakum, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported